Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026)

Ani Pharmaceuticals has disclosed Prepaid Assets across 17 years of filings, most recently posting $22.1 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $22.1 million, down 5.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.1 million (down 5.31% YoY), and the FY2025 annual result was $34.2 million, up 90.35% from the prior year.
• Prepaid Assets came in at $22.1 million for Q1 2026 at Ani Pharmaceuticals, down from $34.2 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $34.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
• The 5-year median for Prepaid Assets is $15.1 million (2025), against an average of $14.7 million.
• Across the five-year window, Prepaid Assets fell 11.03% in 2023 and surged 133.49% in 2024, its largest moves.
• Ani Pharmaceuticals' Prepaid Assets stood at $8.4 million in 2022, then jumped by 107.46% to $17.4 million in 2023, then gained by 3.3% to $18.0 million in 2024, then soared by 90.35% to $34.2 million in 2025, then slumped by 35.45% to $22.1 million in 2026.
• The last three Prepaid Assets figures came in at $22.1 million (Q1 2026), $34.2 million (Q4 2025), and $18.6 million (Q3 2025), per Business Quant data.